Investor Relations Home

There are no items to display.

Stock Quote

MASI (Common Stock)
Exchange
Price
Change (%)
Volume
Data as of Copyright Nasdaq. Minimum 15 minutes delayed.

Online Investor Kit

	Masimo Reports Second Quarter 2017 Financial Results
	2016 Annual Report
	2016 Form 10K
	2017 Proxy Statement
	2017 Proxy Statement Supplement No.1
	2017 Proxy Statement Supplement No. 2

Corporate Profile

We are a global medical technology company that develops, manufactures, and markets a variety of noninvasive monitoring technologies. Our mission is to improve patient outcomes and reduce the cost of care by taking noninvasive monitoring to new sites and applications. We were incorporated in California in May 1989 and reincorporated in Delaware in May 1996.

Our core business is measure through motion and low perfusion arterial blood oxygen saturation and pulse rate monitoring, kno... More >>

Upcoming Events

More >>

There are currently no events to display.

Recent News

RSS Feeds | More >>

05/01/08

Summary Toggle Masimo to Present at Deutsche Bank 33rd Annual Health Care Conference IRVINE, Calif., May 1, 2008 /PRNewswire-FirstCall via COMTEX News Network/ -- Masimo Corporation (Nasdaq: MASI), the inventor of Pulse CO-Oximetry-and-Measure-Through-Motion- and-Low-Perfusion pulse oximetry, today announced that it is scheduled to present at the Deutsche Bank 33rd Annual Health Car
04/29/08

Summary Toggle Masimo Reports First Quarter 2008 Financial Results Record results mark 19th consecutive quarter of revenue growth Q1 2008 Highlights: - Product revenues increased 30% to a record $59.7 million - Shipped 28,600 new pulse oximeters - Rainbow revenues increased 104% IRVINE, Calif., April 29, 2008 /PRNewswire-FirstCall/ -- Masimo Corporation (Nasdaq: MA
04/18/08

Summary Toggle Masimo to Report First Quarter 2008 Financial Results on April 29, 2008 Conference call and webcast with Masimo CEO and CFO to begin after markets close at 2:00 p.m. PT (5:00 p.m.
04/16/08

Summary Toggle Atom Medical Adopts Masimo Rainbow SET Technology IRVINE, Calif., April 16, 2008 /PRNewswire-FirstCall via COMTEX News Network/ -- Masimo (Nasdaq: MASI), the inventor of Pulse CO-Oximetry and Measure-Through-Motion-and-Low-Perfusion pulse oximetry, today announced an agreement with Atom Medical Corporation, a leading global manufacturer of neonatal
04/03/08

Summary Toggle Masimo PVI(TM) Cleared for Market in Japan PVI could help clinicians assess a patient's fluid responsiveness noninvasively, according to a new study published in 'Anesthesia & Analgesia' IRVINE, Calif., April 3, 2008 /PRNewswire-FirstCall/ -- Masimo, the inventor of Pulse CO-Oximetry and Measure-Through Motion and Low Perfusion pulse oximetr
03/25/08

Summary Toggle Schiller AG Adopts Masimo Rainbow SET as Their Technology Platform of Choice for Patient Monitoring Devices Worldwide IRVINE, Calif., March 25, 2008 /PRNewswire-FirstCall via COMTEX News Network/ -- Masimo (Nasdaq: MASI), the inventor of Pulse CO-Oximetry and Measure-Through Motion and Low Perfusion pulse oximetry, today announced an agreement with Switzerland-based Schiller, a leading European manufacturer and sup
03/19/08

Summary Toggle New Study Finds Masimo Rainbow SET Pulse CO-Oximetry(TM) Effective as a Universal Screening Tool to Identify Cases of Unsuspected CO Poisoning in ERs Rhode Island Hospital study identifies 11 cases of unsuspected CO poisoning through universal CO screening with the Masimo Rad-57 Pulse CO-Oximeter(TM) IRVINE, Calif., March 19 /PRNewswire-FirstCall/ -- Masimo, the inventor of Pulse CO-Oximetry and Measure-Through-Motion & Low Perfusion Pulse Oximet
03/14/08

Summary Toggle Masimo to Present at Citi Investment Research 5th Annual Small & Mid-Cap Conference IRVINE, Calif., March 14 /PRNewswire-FirstCall/ -- Masimo Corporation (Nasdaq: MASI), the inventor of Pulse CO-Oximetry and Measure-Through Motion & Low Perfusion pulse oximetry, today announced that it is scheduled to present at the Citi Investment Research 5th Annual Small & Mid-Cap Conference at
03/12/08

Summary Toggle University of Michigan Hospitals and Health Centers Completes System-Wide Conversion to Masimo SET Pulse Oximetry Technology Conversion helps U-M Hospitals and Health Centers, named one of America's best hospitals by U.S.
03/06/08

Summary Toggle New Clinical Studies Presented at the 14th World Congress of Anesthesiology Demonstrate Masimo Advancements in Patient Care Noninvasive Hemoglobin Receives Rave Reviews from Attendees at Masimo's Commercial Exhibit IRVINE, Calif., March 6 /PRNewswire-FirstCall/ -- Masimo, the inventor of Pulse CO-Oximetry(TM) and Measure-Through Motion and Low Perfusion pulse oximetry, reported that multiple clinical studies demonstratin

Receive E-mail Alerts

To request a copy of the Annual Report, click here .